国产在线91精品,日韩在线国产,国产国产精品人在线视,国产性精品,91啦九色,亚洲精品宾馆在线精品酒店,日本99热

Recently, C&D Emerging Industry Equity Investment has received several industry awards. It was ranked NO. 3 on the “2025 Top 100 Industrial Investors” list released by FOF Weekly, and was named one of the “Top 50 Best Corporate Venture Investors in China for 2024” by CVINFO. In addition, several of its portfolio companies—including Impact Therapeutics, Pins Medical, Aidite, Narwal Robotics, SJ SEMI, Kaida Hengye, and AMiner—also received multiple awards on the CVINFO list. In addition, in the “2024 China Best Institutional LP List” released by Chulei Research Institute, C&D Emerging Industry Equity Investment was recognized as one of the “Top 20 Best Institutional LPs in China for 2024” and “Top 10 Best Direct Investment LPs in China for 2024.”

C&D Emerging Industry Equity Investment will remain committed to the mission of "exploring new values for more emerging enterprises to achieve better development", continue to provide unwavering assistance to exceptional fund managers and entrepreneurs, actively promote industrial upgrading and structural optimization, and inject momentum into the development of emerging industries.